Golgi protein ACBD3 downregulation sensitizes cells to ferroptosis
Cell Biology International · 2024
DOI: 10.1002/cbin.12213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2024. Verfasst von Ying Qian und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Ferroptosis, Iron, Membrane Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Provincial Department of Education, Anhui Institute of Translational Medicine.
Abstract (Originalsprache)
Ferroptosis, a form of cell death driven by iron‐dependent lipid peroxidation, is emerging as a promising target in cancer therapy. It is regulated by a network of molecules and pathways that modulate lipid metabolism, iron homeostasis and redox balance, and related processes. However, there are still numerous regulatory molecules intricately involved in ferroptosis that remain to be identified. Here, we indicated that suppression of Golgi protein acyl‐coenzyme A binding domain A containing 3 (ACBD3) increased the sensitivity of Henrieta Lacks and PANC1 cells to ferroptosis. ACBD3 knockdown increases labile iron levels by promoting ferritinophagy. This increase in free iron, coupled with reduced levels of glutathione peroxidase 4 due to ACBD3 knockdown, leads to the accumulation of reactive oxygen species and lipid peroxides. Moreover, ACBD3 knockdown also results in elevated levels of polyunsaturated fatty acid‐containing glycerophospholipids through mechanisms that remain to be elucidated. Furthermore, inhibition of ferrtinophagy in ACBD3 downregulated cells by knocking down the nuclear receptor co‐activator 4 or Bafilomycin A1 treatment impeded ferroptosis. Collectively, our findings highlight the pivotal role of ACBD3 in governing cellular resistance to ferroptosis and suggest that pharmacological manipulation of ACBD3 levels is a promising strategy for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Anhui Medical University, Hefei, China.
- State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
- Department of Wound Repair and Plastic and Aesthetic Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Anhui Public Health Clinical Center, Hefei, China.
- Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, China.
Förderung
- National Natural Science Foundation of China
- Anhui Provincial Department of Education
- Anhui Institute of Translational Medicine
Zitieren
APA
Qian, Y., Ma, S., Qiu, R., Sun, Z., Liu, W., Wu, F., Lam, S. M., Xia, Z., Wang, K., Fang, L., Shui, G., & Cao, X. (2024). Golgi protein ACBD3 downregulation sensitizes cells to ferroptosis. Cell Biology International. https://doi.org/10.1002/cbin.12213
Vancouver
Qian Y, Ma S, Qiu R, Sun Z, Liu W, Wu F, et al. Golgi protein ACBD3 downregulation sensitizes cells to ferroptosis. Cell Biology International. 2024. doi:10.1002/cbin.12213
BibTeX
@article{Qian2024,
author = {Qian, Ying and Ma, Shanchuan and Qiu, Rong and Sun, Zhiyang and Liu, Wei and Wu, Fan and Lam, Sin Man and Xia, Zhengguo and Wang, Kezhen and Fang, Linshen and Shui, Guanghou and Cao, Xinwang},
title = {Golgi protein ACBD3 downregulation sensitizes cells to ferroptosis},
journal = {Cell Biology International},
year = {2024},
doi = {10.1002/cbin.12213}
}
EUVIMED